Zomedica (ZOMDF) Return on Sales [ROS] (2021 - 2026)
Zomedica's Return on Sales [ROS] was -34.60% in Q3 2026, up 47.01 percentage points from -81.61% a year earlier and up 8.33 percentage points from the prior quarter.
Powered by 
Analysis
Zomedica (ZOMDF) Return on Sales [ROS] (2021 - 2026) Analysis & Trends
On a trailing twelve-month basis, Zomedica's Return on Sales [ROS] was -45.43% through Sep 30, 2026, up 251.13 percentage points year-over-year; for FY2025, it came in at -263.36%, down 76.25 percentage points from FY2024.
- Return on Sales [ROS] has now declined for three consecutive years, though with a four-year change of +253.80 percentage points (FY2021 to FY2025).
- In earlier years, Return on Sales [ROS] was -187.11% in FY2024 (-15.29 pp), -171.82% in FY2023 (-56.01 pp), -115.81% in FY2022 (+401.34 pp) and -517.15% in FY2021.
- The Q3 2026 figure marks the highest quarterly Return on Sales [ROS] in data going back to Q1 2021.
- Compared with a year earlier, Return on Sales [ROS] has increased for six straight quarters, with an average year-over-year change of +101.62 percentage points over the last eight quarters.
- The best year-over-year quarter for Return on Sales [ROS] over five years was Q2 2022 (a gain of 33167.77 percentage points); the worst was Q1 2025 (a drop of 827.19 percentage points).
- Per Business Quant data, ZOMDF's Return on Sales [ROS] in the three quarters before Q3 2026 was -42.92% (Q2 2026), -55.69% (Q1 2026) and -49.32% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 32.98% |
| 10 | Zomedica | 97.99 Mn | -87.03 Mn | 6.04 Mn | -34.60% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -34.60% |
| Jun 30, 2026 | -42.92% |
| Mar 31, 2026 | -55.69% |
| Dec 31, 2025 | -49.32% |
| Sep 30, 2025 | -81.61% |
| Jun 30, 2025 | -115.38% |
| Mar 31, 2025 | -993.05% |
| Dec 31, 2024 | -103.36% |
| Sep 30, 2024 | -106.33% |
| Jun 30, 2024 | -408.86% |
| Mar 31, 2024 | -165.86% |
| Dec 31, 2023 | -314.46% |
| Sep 30, 2023 | -93.71% |
| Jun 30, 2023 | -111.99% |
| Mar 31, 2023 | -137.03% |
| Dec 31, 2022 | -83.42% |
| Sep 30, 2022 | -138.02% |
| Jun 30, 2022 | -138.48% |
| Mar 31, 2022 | -115.01% |
| Dec 31, 2021 | -141.26% |
API Access
Zomedica Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ZOMDF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "ZOMDF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ZOMDF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();